MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
−Removed: On August 26, 2016, the Company’s common stock became listed and began trading on the Nasdaq Capital Market stock exchange where it trades under the symbol BMRA.
−Removed: Previous to that date, the Company’s stock traded on the OTC Bulletin Board.
−Removed: As of August 29, 2022, the number of holders of record of Biomerica's common stock was approximately 800, excluding stock held in street name.
−Removed: The number of record holders does not bear any relationship to the number of beneficial owners of the common stock as most of the Company’s common stock is held in street name at securities brokerage firms.
−Removed: The Company has not paid any cash dividends on its common stock in the past and does not plan to pay any cash dividends on its common stock in the foreseeable future.
−Removed: The Company's Board of Directors (“Board”) intends, for the foreseeable future, to retain any earnings to finance the continued operation and expansion of the Company's business.
−Removed: We did not sell any unregistered equity securities during the year ended May 31, 2022.
−Removed: We did not purchase any of our shares of common stock or other securities during our fiscal year ended May 31, 2022.
−Removed: The table below provides information relating to our equity compensation plans as of May 31, 2022:
−Removed: Securities Remaining
−Removed: Available for Future Issuance
−Removed: Under Compensation Plans
−Removed: (Excluding those Reflected in
−Removed: Second Column)
−Removed: Securities Plan
−Removed: Number of Securities to be
−Removed: Issued Upon Exercise of
−Removed: Outstanding Options
−Removed: Compensation Plans
−Removed: Weighted-Average
−Removed: Exercise Price of
−Removed: Outstanding Options
+Added: Company’s common stock is listed for trading on the Nasdaq Capital Market stock exchange under the symbol BMRA.
+Added: of August 25, 2023, the number of holders of record of Biomerica’s common stock was approximately 800, excluding stock held in
+Added: The number of record holders does not bear any relationship to the number of beneficial owners of the common stock as most
+Added: of the Company’s common stock is held in street name at securities brokerage firms.
+Added: Company has not paid any cash dividends on its common stock in the past and does not plan to pay any cash dividends on its common stock
+Added: in the foreseeable future.
+Added: The Company intends, for the foreseeable future, to retain any earnings to finance the continued operation
+Added: and expansion of the Company’s business.
+Added: did not purchase any of our shares of common stock or other securities during our fiscal year ended May 31, 2023.
+Added: table below provides information relating to our equity compensation plans as of May 31, 2023:
+Added: Plan Category
+Added: of Securities to be Issued Upon Exercise of Outstanding Options
+Added: Plans Weighted-Average Exercise Price of Outstanding Options
+Added: Remaining Available for Future Issuance Under Compensation Plans (Excluding those Reflected in Second Column)
Equity compensation
−Removed: Plans approved by
−Removed: Securities holders
−Removed: Not required.
+Added: Plans approved by Securities holders
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.